Advances in the topical treatment of diabetic foot ulcers
- PMID: 22429013
- DOI: 10.2174/157339912800563963
Advances in the topical treatment of diabetic foot ulcers
Abstract
The diabetic foot remains a major cause of morbidity worldwide. Even though considerable progress has been achieved over the past years, there is still an urgent need for improvement. While established therapeutic modalities (revascularization, casting and debridement) remain the mainstay of management, there is, therefore, continuous development of new treatment options. This review provides an outlook of advances in topical treatment, including bioengineered skin substitutes (such as Dermagraft, Apligraf, HYAFF, OASIS and Graftjacket), extracellular matrix proteins (such as Hyalofill and E-matrix), as well as miscellaneous further therapeutic adjuncts. Although promising, new therapies should not, for the time being, constitute the basis of management, since clinical experience has not yet confirmed their effectiveness in hard-to-heal diabetic foot ulcers. Furthermore, their cost-effectiveness merits further investigation. Instead, they should only be considered in combination with established treatments or be attempted when these have not been successful. Moreover, we should not be oblivious to the fact that established and emerging treatments need to be practised in the setting of multidisciplinary foot clinics to reduce the number of amputations.
Similar articles
-
The diabetic foot: established and emerging treatments.Acta Clin Belg. 2007 Jul-Aug;62(4):230-8. doi: 10.1179/acb.2007.037. Acta Clin Belg. 2007. PMID: 17849694 Review.
-
Growth factors for treating diabetic foot ulcers.Cochrane Database Syst Rev. 2015 Oct 28;2015(10):CD008548. doi: 10.1002/14651858.CD008548.pub2. Cochrane Database Syst Rev. 2015. PMID: 26509249 Free PMC article. Review.
-
Clinical management of diabetic ulcers.Clin Geriatr Med. 2013 May;29(2):433-41. doi: 10.1016/j.cger.2013.01.007. Clin Geriatr Med. 2013. PMID: 23571038
-
Topical and biologic therapies for diabetic foot ulcers.Med Clin North Am. 2013 Sep;97(5):883-98. doi: 10.1016/j.mcna.2013.03.014. Epub 2013 May 18. Med Clin North Am. 2013. PMID: 23992899
-
A comparative analysis of skin substitutes used in the management of diabetic foot ulcers.J Wound Care. 2016 Oct 1;25(Sup10):S8-S17. doi: 10.12968/jowc.2016.25.Sup10.S8. J Wound Care. 2016. PMID: 27681811
Cited by
-
A Comparison of Conventional Collagen Sponge and Collagen-Gelatin Sponge in Wound Healing.Biomed Res Int. 2016;2016:4567146. doi: 10.1155/2016/4567146. Epub 2016 Apr 27. Biomed Res Int. 2016. PMID: 27218103 Free PMC article.
-
Wound Healing: Biologics, Skin Substitutes, Biomembranes and Scaffolds.Healthcare (Basel). 2014 Sep 10;2(3):356-400. doi: 10.3390/healthcare2030356. Healthcare (Basel). 2014. PMID: 27429283 Free PMC article. Review.
-
Comparison of human umbilical cord blood-derived mesenchymal stem cells with healthy fibroblasts on wound-healing activity of diabetic fibroblasts.Int Wound J. 2018 Feb;15(1):133-139. doi: 10.1111/iwj.12849. Epub 2017 Nov 7. Int Wound J. 2018. PMID: 29115054 Free PMC article.
-
Oxidized Regenerated Cellulose/Collagen Dressings: Review of Evidence and Recommendations.Adv Skin Wound Care. 2017 Nov;30(11S Suppl 1):S1-S18. doi: 10.1097/01.ASW.0000525951.20270.6c. Adv Skin Wound Care. 2017. PMID: 29049055 Free PMC article. Review.
-
Quantification of the differential expression levels of microRNA-203 in different degrees of diabetic foot.Int J Clin Exp Pathol. 2015 Oct 1;8(10):13416-20. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26722550 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous